|
|||||
|
|
A prospective, open-label safety and efficacy study of combination treatment with bortezomib (PS-341, velcade and melphalan in patients with relapsed or refractory multiple myeloma |
|
| Authors: | Yang Hank H Vescio Robert Schenkein David Berenson James R |
| Affiliation: | Department of Medicine, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, California 90084, USA. |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |